CASSIDY DALTON: Open Payments
NPI 1568001477 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 12 payments from 6 companies in 2025. Trend: 2023 $297 · 2024 $1,634 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $283 |
| Sumitomo Pharma America, Inc. | 4 | $121 |
| ABBVIE INC. | 2 | $51 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $27 |
| Procept Biorobotics Corporation | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
Products named: RYBREVANT, GEMTESA, BOTOX, Magic3 Go Intermittent Urinary Catheter, AQUABEAM ROBOTIC SYSTEM, ADSTILADRIN.
Industry payments across CA — which companies pay providers there.
